HealthRx lists $99/month on a 12-month prepaid semaglutide plan; Lemonaid Health current details were not published or could not be verified on the captured page.

Semaglutide $99, Tirzepatide $129, no insurance needed and lifetime price guarantee. Lemonaid details were not verified; treatment is subject to clinician review.

Lemonaid Health: clinician-reviewed online weight-management care with many details not verified. BreezeMeds: injectable and oral GLP-1 options starting at $199 with discreet shipping.

JoinFridays starts at $117/month with no long-term contracts and active promo codes. Wellorithm offers 50-state clinician coverage and starting options from $147.

Treatment is available only when a licensed clinician determines it is medically appropriate. bmiMD lists tirzepatide pricing from $179 down to $139/mo with free shipping.

JoinFridays starts at $117/month with compounded tirzepatide and semaglutide and no long-term contracts. Ro.co lets you get started online for just $39 with the Wegovy pill.

JoinFridays starts at $117/month with compounded tirzepatide and semaglutide and no long-term contracts. Sprout Health offers $50 off first month, then $249/month.

JoinFridays starts at $117/month with compounded tirzepatide and semaglutide and no long-term contracts. RxActivate gates pricing behind an eligibility quiz.

JoinFridays starts at $117/month with compounded tirzepatide and semaglutide and no long-term contracts. Maximus charges $132.99/month, uses US pharmacies and licensed doctors.

JoinFridays starts at $117/month with compounded tirzepatide and semaglutide and no long-term contracts. ReadyRx pricing and details were not verified on capture.

JoinFridays starts at $117/month with compounded tirzepatide and semaglutide and no long-term contracts. Measured advertises compounded semaglutide from $89/mo and free 2-day shipping.

JoinFridays offers compounded GLP-1 options starting at $117/month with no long-term contracts. Luvo Health lists ongoing support and dose changes; pricing was not verified.